Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5282590
Max Phase: Preclinical
Molecular Formula: C34H29F4N3O4
Molecular Weight: 619.62
Associated Items:
ID: ALA5282590
Max Phase: Preclinical
Molecular Formula: C34H29F4N3O4
Molecular Weight: 619.62
Associated Items:
Canonical SMILES: CCOC(=O)N1C/C(=C\c2ccc(F)cc2F)C(=O)[C@@]2(C1)[C@H](c1ccc(F)cc1F)[C@H]1CCCN1[C@]21C(=O)Nc2ccccc21
Standard InChI: InChI=1S/C34H29F4N3O4/c1-2-45-32(44)40-17-20(14-19-9-10-21(35)15-25(19)37)30(42)33(18-40)29(23-12-11-22(36)16-26(23)38)28-8-5-13-41(28)34(33)24-6-3-4-7-27(24)39-31(34)43/h3-4,6-7,9-12,14-16,28-29H,2,5,8,13,17-18H2,1H3,(H,39,43)/b20-14+/t28-,29-,33-,34-/m1/s1
Standard InChI Key: HEXGLNVMLQLUNY-KZEKLOROSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 619.62 | Molecular Weight (Monoisotopic): 619.2094 | AlogP: 5.76 | #Rotatable Bonds: 3 |
Polar Surface Area: 78.95 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.49 | CX Basic pKa: 6.99 | CX LogP: 5.97 | CX LogD: 5.83 |
Aromatic Rings: 3 | Heavy Atoms: 45 | QED Weighted: 0.30 | Np Likeness Score: -0.20 |
1. Brandão P, Marques C, Burke AJ, Pineiro M.. (2021) The application of isatin-based multicomponent-reactions in the quest for new bioactive and druglike molecules., 211 [PMID:33421712] [10.1016/j.ejmech.2020.113102] |
Source(1):